Published Aug 08, 2018

Harbour BioMed inks $350 million deal for rights to A167

Member News

Related or similar articles

May 17, 2024

Streamlining Procurement: Labshares Partners with Labviva for Enhanced Access and Efficiency

In the fast-paced world of biotech innovation, easy access to crucial resources is vital for research success. That's why Labshares is excited to share news of our partnership with Labviva, a top procurement platform reshaping how scientists obtain l
Labshares News
March 20, 2025

Labshares x BYTE51: A Game-Changing Partnership to Navigate Fundraising

Labshares News
April 25, 2024

Laboratory Space for Emerging Biotechs:  Best Practices and Tips from Labshares 

Labshares News